Innate immune cellular therapeutics in transplantation
Successful organ transplantation provides an opportunity to extend the lives of patients with end-stage organ failure. Selectively suppressing the donor-specific alloimmune response, however, remains challenging without the continuous use of non-specific immunosuppressive medications, which have mul...
Main Authors: | Leah C. Ott, Alex G. Cuenca |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Transplantation |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/frtra.2023.1067512/full |
Similar Items
-
Immunoregulatory functions of innate lymphoid cells
by: Sarah Q. Crome, et al.
Published: (2018-11-01) -
Cytokine Networks between Innate Lymphoid Cells and Myeloid Cells
by: Arthur Mortha, et al.
Published: (2018-02-01) -
Reduced Type 2 Innate Lymphocyte Cell Frequencies in Patent <i>Wuchereria bancrofti</i>-Infected Individuals
by: Ruth S. E. Tamadaho, et al.
Published: (2023-04-01) -
Local and Systemic Injections of Human Cord Blood Myeloid-Derived Suppressor Cells to Prevent Graft Rejection in Corneal Transplantation
by: Jae-young Lee, et al.
Published: (2022-12-01) -
Editorial: The regulatory immune system as a target to improve adjuvants and novel vaccines
by: Carlos Jiménez-Cortegana, et al.
Published: (2023-06-01)